Edgewise Therapeutics (EWTX): Assessing Valuation Following Recent Share Price Volatility [Yahoo! Finance]
Edgewise Therapeutics, Inc. (EWTX)
Company Research
Source: Yahoo! Finance
Investors are taking stock of its performance as they consider what might drive the next move for this biotech player. See our latest analysis for Edgewise Therapeutics. Edgewise Therapeutics has seen some wild price action lately, but zooming out tells a bigger story. Even with a strong 90-day share price return of 32.1%, the 1-year total shareholder return is still down sharply. That recent momentum could signal shifting sentiment, but longer-term investors have felt the sting. If you're on the lookout for other healthcare standouts or fresh opportunities in biotech, our Healthcare Stocks Screener is a smart way to spot what's gaining traction. See the full list for free. But does the latest surge reflect untapped value in Edgewise Therapeutics, or have recent gains already incorporated all the hope for future success? Is there a real buying opportunity here, or has the market priced in what's ahead? Price-to-Book Ratio of 3.3x: Is it justified? Edgewise Therapeutics cur
Show less
Read more
Impact Snapshot
Event Time:
EWTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EWTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EWTX alerts
High impacting Edgewise Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
EWTX
News
- Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing RulesPR Newswire
- Edgewise Therapeutics (NASDAQ:EWTX) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=EWTX&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall StrMarketBeat
- Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors [Yahoo! Finance]Yahoo! Finance
- Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of DirectorsPR Newswire
- Will Edgewise Therapeutics' (EWTX) New CFO Mark a Shift in Its Commercial Strategy? [Yahoo! Finance]Yahoo! Finance
EWTX
Earnings
- 11/6/25 - Beat
EWTX
Sec Filings
- 11/24/25 - Form 4
- 11/24/25 - Form 3
- 11/20/25 - Form 8-K
- EWTX's page on the SEC website